IEEE Spectrum - AI
· Generative Media
How a Google DeepMind Spin-off Hunts Hidden Drug Targets
For more than a decade, artificial intelligence has been touted as a way to dramatically accelerate drug discovery. Yet despite billions of dollars in investment, relatively few AI-designed medicines have made it to patients. That’s partially because the timelines for careful drug testing can’t be easily compressed—and